NLS Pharma’s CEO Alex Zwyer interviewed at Business Worldwide Magazine

Businnes Worldwide Magazine interviews NLS Pharma's CEO Alex Zwyer

Conditions like Attention Deficit Hyperactivity Disorder are costly both to individuals and society. We talk to Alex Zwyer, CEO of NLS-1 Pharma AG (NLS), a cutting-edge biotech company, about their novel treatments for ADHD and what makes their company so great at innovation.

Read full article: